Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia Jan 29, 2025 9:30am EST
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program Jul 12, 2024 10:00am EDT